Remove Online Pharmacies Remove Regulations Remove Research
article thumbnail

CDER’s Office of Compliance Kicks Off Annual Report Season with Rundown of 2023’s Major Public Health Enforcement Initiatives

FDA Law Blog: Biosimilars

Claud — The Office of Compliance (OC) at FDA’s Center for Drug Evaluation and Research (CDER) had a role in many of the major public health enforcement matters you may have read about last year. This is another area in which FDA works with industry to try to ensure voluntary compliance from regulated entities. By John W.M.

article thumbnail

How Pharma-Funded Groups Lie About Personal Drug Imports

Policy Prescription

The NeedyMeds host describes PSM as a “not-for-profit organization focused entirely on researching the danger of counterfeit drugs in America and educating the public about how to stay safe from them.”. and licensed by your state board of pharmacy.” Safdar, the executive director of the Partnership for Safe Medicine (PSM).

article thumbnail

DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees

Policy Prescription

This epic counterfeit drug debacle had nothing to do with the personal importation of less expensive prescription drugs or foreign online pharmacies. pharmacies and wholesalers allegedly flouting the rules. However, to do that, the regulations must prevent the creation of fake DSCSA pedigrees.